胰十二指肠切除术后广谱抗生素预防的早期采纳:随机试验数据的评估
该研究基于美国外科医师学会国家手术质量改进计划胰腺切除靶向数据库,纳入2017至2024年行胰十二指肠切除术的27,294例患者,评估支持广谱青霉素预防的I级证据传播后临床采纳情况。结果显示,广谱抗生素使用率从证据传播前的38.2%升至传播后的56.2%,且与试验发表同步增加(OR 1.40,95%CI 1.09-1.81)。
要点
- 胰十二指肠切除术后广谱抗生素使用率在证据发表后由38.2%升至56.2%。
- 使用增加与试验发表同步,OR 1.40(95%CI 1.09-1.81)。
- 术前胆道支架患者使用广谱抗生素的几率更高(OR 1.25,95%CI 1.05-1.48)。
核心结论
- 支持广谱青霉素用于胰十二指肠切除术的近期证据发表后,广谱抗生素使用增加,尤其在胆道支架患者中。
研究设计与样本
- 基于美国外科医师学会国家手术质量改进计划胰腺切除靶向数据库的回归间断分析,纳入2017至2024年27,294例来自220家医院的胰十二指肠切除术患者。
主要发现
- 广谱抗生素使用率在证据传播前为38.2%,传播后为56.2%。
- 使用增加与试验发表同步(时间与发表状态交互作用;OR 1.40,95%CI 1.09-1.81)。
- 更多医院显示使用增加而非不变或减少。
- 术前胆道支架患者使用广谱抗生素的几率更高(OR 1.25,95%CI 1.05-1.48)。
- 黑人/非洲裔美国种族与接受广谱预防的几率较低相关(OR 0.70,95%CI 0.50-0.98)。
临床怎么用
- 临床可参考证据支持在胰十二指肠切除术中采用广谱青霉素预防,尤其对术前胆道支架患者。
- 需关注种族差异对广谱抗生素预防使用的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who receive piperacillin-tazobactam when undergoing pancreatoduodenectomy have reduced postoperative surgical site infection, pancreatic fistula, and sequelae of surgical site infection compared with patients who received cefoxitin, supporting broad-spectrum penicillin prophylaxis as standard care. However, evidence-based practices can take years to integrate widely, and the rate of clinical uptake after pragmatic surgical trials is undefined. Our objective was to evaluate broad-spectrum antimicrobial use in pancreatoduodenectomy after the dissemination of level I evidence supporting this practice. METHODS: Patients undergoing pancreatoduodenectomy from 2017 to 2024 were identified using the American College of Surgeons National Surgical Quality Improvement Program pancreatectomy targeted database. A regression discontinuity analysis using a logistic model was constructed to assess changes in practice around trial publication. An additional mixed-model logistic regression was used to evaluate patient predictors influencing antibiotic use. RESULTS: Among the 27,294 patients from 220 hospitals, broad-spectrum use was 38.2% before dissemination of findings and 56.2% after trial publication. An increase in use of broad-spectrum antibiotics was coincident with the study publication (time by publication status interaction; odds ratio, 1.40; 95% confidence interval, 1.09-1.81), with more hospitals demonstrating an increase in use than either no change or decrease in use. Patients with an indwelling preoperative biliary stent demonstrated greater odds of broad-spectrum antibiotic use (odds ratio, 1.25; 95% confidence interval, 1.05-1.48), whereas Black/African American race was associated with lower odds of receiving broad-spectrum prophylaxis (odds ratio, 0.70; 95% confidence interval, 0.50-0.98). CONCLUSION: Increased broad-spectrum penicillin use for pancreatoduodenectomies was observed, especially in patients with biliary stents, following recent evidence supporting its use as standard practice.
引用
- Peters XD, Liu JK, Cohen ME, et al. Broad-spectrum antibiotic prophylaxis for pancreatoduodenectomy: Assessment of early adoption of randomized trial data. Surgery. 2026. PMID: 42242164. doi:10.1016/j.surg.2026.110316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。